Silvestrol
99%
- Product Code: 96531
CAS:
697235-38-4
| Molecular Weight: | 654.66 g./mol | Molecular Formula: | C₃₄H₃₈O₁₃ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20°C |
Product Description:
Silvestrol has shown significant potential in cancer research due to its ability to inhibit protein synthesis in cancer cells. It selectively targets the eukaryotic initiation factor 4A (eIF4A), disrupting the translation of specific mRNAs that are crucial for tumor growth and survival. This mechanism makes it particularly effective against certain types of cancers, such as leukemia, breast cancer, and pancreatic cancer, where these proteins are overexpressed. Additionally, silvestrol has demonstrated antiviral properties, particularly against RNA viruses like Ebola and coronavirus, by interfering with viral replication. Its unique mode of action and selectivity continue to make it a promising candidate for further drug development and therapeutic applications.
Product Specification:
| Test | Specification |
|---|---|
| PURITY | 98.5-100 |
| Infrared spectrum | Conforms to Structure |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.001 | 10-20 days | ฿138,900.00 |
+
-
|
Silvestrol
Silvestrol has shown significant potential in cancer research due to its ability to inhibit protein synthesis in cancer cells. It selectively targets the eukaryotic initiation factor 4A (eIF4A), disrupting the translation of specific mRNAs that are crucial for tumor growth and survival. This mechanism makes it particularly effective against certain types of cancers, such as leukemia, breast cancer, and pancreatic cancer, where these proteins are overexpressed. Additionally, silvestrol has demonstrated antiviral properties, particularly against RNA viruses like Ebola and coronavirus, by interfering with viral replication. Its unique mode of action and selectivity continue to make it a promising candidate for further drug development and therapeutic applications.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :